| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.avonlifesciences.com | |
| Market Cap | 9.34 Cr. | |
| Enterprise Value(EV) | 149.64 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -2.29 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 42.19 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | -55.26 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | -0.07 | Calculated using Price: 3.92 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 2.38 Cr. | 23,825,000 Shares |
| FaceValue | 10 | |
| About Kobo Biotech Ltd. | ||
| AVON Organics Limited (AOL) was started by P R Agarwal, Rajesh Agarwal along with late G S Sidhu .It is located at Madhupala Towers Greenlands, Hyderabad 500 016, India. The company's transition from a machinery manufacturer to a full-fledged chemical manufacturer saw the company foraying into the highly technology-intensive area of Diketene and its derivatives. | ||
| 1 Day |
|
+4.96% |
| 1 Week |
|
+3.42% |
| 1 Month |
|
+11.32% |
| 3 Month |
|
-1.63% |
| 6 Month |
|
+52.71% |
| 1 Year |
|
+56.67% |
| 2 Year |
|
-31.66% |
| 5 Year |
|
+6.02% |
| 10 Year |
|
-55.57% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | -103.9 | -233.98 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Return on Capital Employed (%) | -8.67 | -1.32 | -2.78 | -5.12 | -5.74 | -3.93 | -5.31 | -17.59 | -36.84 | |
| Return on Assets (%) | -11.4 | -6.43 | -7.5 | -9.6 | -10.08 | -8.83 | -8.24 | -9.83 | -7.19 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 14 | 6 | -19 | -43 | -67 | -88 | -107 | -122 | -128 | -130 | |
| Non Curr. Liab. | 74 | 74 | 64 | 47 | 40 | 40 | 39 | 38 | 37 | 37 | |
| Curr. Liab. | 164 | 180 | 207 | 242 | 266 | 284 | 299 | 163 | 166 | 166 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 252 | 260 | 252 | 246 | 239 | 236 | 231 | 79 | 75 | 73 | |
| Non Curr. Assets | 110 | 102 | 95 | 89 | 83 | 77 | 71 | 42 | 38 | 36 | |
| Curr. Assets | 142 | 158 | 157 | 157 | 157 | 159 | 159 | 38 | 38 | 38 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 252 | 260 | 252 | 246 | 239 | 236 | 231 | 79 | 75 | 73 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 29 | 33 | |||||||||
| Other Income | 1 | 1 | 6 | 0 | 1 | 2 | 0 | 133 | 0 | 0 | |
| Total Income | 30 | 34 | 6 | 0 | 1 | 2 | 0 | 133 | 0 | 0 | |
| Total Expenditure | -39 | -29 | -4 | -3 | -3 | -3 | -3 | -144 | -2 | -1 | |
| PBIDT | -9 | 5 | 2 | -3 | -2 | -1 | -3 | -10 | -1 | -1 | |
| Interest | -16 | -14 | -14 | -15 | -14 | -14 | -11 | 0 | |||
| Depreciation | -8 | -7 | -7 | -6 | -6 | -6 | -6 | -5 | -4 | -4 | |
| Taxation | |||||||||||
| Exceptional Items | 3 | -2 | |||||||||
| PAT | -30 | -16 | -19 | -24 | -24 | -21 | -19 | -15 | -6 | -5 | |
| Adjusted EPS | -13 | -7 | -8 | -10 | -10 | -9 | -8 | -6 | -2 | -2 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 11 | 19 | 6 | 32 | 31 | 21 | 14 | 3 | 94 | 1 | |
| Cash Fr. Inv. | -5 | 25 | |||||||||
| Cash Fr. Finan. | -7 | -21 | -5 | -33 | -31 | -21 | -14 | -1 | -120 | -1 | |
| Net Change | -1 | -1 | 0 | 0 | 1 | -1 | |||||
| Cash & Cash Eqvt | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 0 | 0 |
|
Fri, 26 Apr 2024
Compliance Certificate Under Regulation 7(3) Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations for the year ended 31st March 2024 |
|
Sat, 20 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance Certificate under Regulation 74-5 of SEBI DP Regulation |
|
Sat, 20 Apr 2024
Certificate Pursuant To Regulation 40(9) Of SEBI LODR Certificate pursuant to Regulation 40(9) of SEBI LODR |
| Tue, 30 Apr 2024 |
Higher Delivery Quantity
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
High Increase in 1 Month
|
High Increase in 6 Months
|
